Polaris Founders Capital - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $95,001.41 +0.48%
Ethereum $3,383.87 +1.15%
BNB $712.97 +2.33%
Optimism $1.86 +0.30%
Arbitrum $0.77 +2.06%
Solana $194.26 +4.78%
Polygon $0.49 +1.46%
Cosmos $6.60 +1.94%
Avalanche $37.25 +1.19%

Bitcoin $95,001.41 +0.48%
Ethereum $3,383.87 +1.15%
BNB $712.97 +2.33%
Optimism $1.86 +0.30%
Arbitrum $0.77 +2.06%
Solana $194.26 +4.78%
Polygon $0.49 +1.46%
Cosmos $6.60 +1.94%
Avalanche $37.25 +1.19%

Polaris Founders Capital

investment firm

Summary
Investments
Exits
Employees

About

Polaris Founders Capital makes substantial investments in fast-growing companies.

http://polarisfc.com/

Highlights

Employee Profiles

Details

Founded date: Jan 1, 1997
Operating Status: Active
Investor Type: Venture Capital

Polaris Founders Capital makes substantial investments in fast-growing companies.

Investments

Number of Investments

Number of Lead Investments

4

0

Polaris Founders Capital has made 4 investments. Their most recent investment was on Jul 20, 2021, when Amylyx Pharmaceuticals raised $135M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Jul 20, 2021 Amylyx Pharmaceuticals	Series C	$135M	Biotechnology	—
Apr 27, 2021 Sesame	Series Unknown	$24M	E-Commerce	—
Mar 3, 2020 Akouos	Series B	$105M	Biotechnology	—
Jul 23, 2019 Frequency Therapeutics	Series C	—	Biotechnology	—

Employee Profiles

Number of Employee Profiles

1

Polaris Founders Capital has 1 current employee profiles, including Executive Jon Flint

Executive

Exits

Polaris Founders Capital has had 3 exits. Polaris Founders Capital most notable exits include Amylyx Pharmaceuticals , Akouos

Date	Company Name	Exit Type	Industry
Jan 7, 2022	Amylyx Pharmaceuticals	IPO	Biotechnology	Detail
Jun 25, 2020	Akouos	M&A	Biotechnology	Detail
Oct 2, 2019	Frequency Therapeutics	IPO	Biotechnology	Detail